Clinical Trial

Unveiling Physiological and Psychosocial Pain Components with an Artificial Intelligence Based Telemonitoring Tool

Study acronym: pAIn-sense
Recruiting
View on ClinicalTrials.gov →
Summary
The pAIn-sense study aims to revolutionize the monitoring and treatment of chronic pain, a major health concern that significantly impacts psychological well-being and quality of life. Traditional approaches to pain management face challenges like unspecific drug use and high healthcare costs, and they often leave patients dissatisfied. PAIn-sense aims at comprehensively understanding pain from both physical and emotional perspectives. To accomplish this, the study will employ advanced Artificial Intelligence (AI) techniques and wearable sensing technology. The study aims to monitor patients continuously, during both day and night activities, to gather a multidimensional set of data on their physiological, psychosocial, and pain conditions.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-09-13; most recent amendment 2025-01-17.
Trial Details
NCT Number NCT06044584
Lead Sponsor ETH Zurich
Collaborators: Balgrist University Hospital
Conditions Nociceptive Pain, Neuropathic Pain
Enrollment 150 participants
Start Date 2023-09-29
Primary Completion 2028-12-15 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-20